AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
US drugmaker Wyeth says that the US Food and Drug Administration has granted final approval to the company's application for Alavert (loratadine) a generic version of Schering-Plough's Claritin brand of the antihistamine which was approved for over-the-counter sale towards the end of last year (Marketletter December 2, 2002), the first non-sedating antihistamine to be switched to non-prescription status.E
S-P began selling its OTC version of Claritin on December 10, at prices significantly discounted from its prescription cost, in advance of the expiry of the final US patent on the drug on December 19.
Wyeth said that it would ...